Search Results 411-420 of 17294 for Cyclophosphamide

  1. A Study Of NT-175 In Adult Subjects With Unresectable, Advanced, And/or Metastatic Solid Tumors That Are Positive For HLA-A*02:01 And The TP53 R175H Mutation - Mayo Clinic

    * History of severe immediate hypersensitivity reaction to cyclophosphamide, fludarabine, or rIL-2; or known sensitivity or allergy to methotrexate ...

  2. A Study of LY2784544 for Patients with Myeloproliferative Disorders - Mayo Clinic

    ... cyclophosphamide, ifosfamide, tamoxifen, efavirenz, propofol, methadone, and bupropion); Currently being treated with warfarin or one of its derivatives ...

  3. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  4. Clinical trials - Oncology (Medical)

    Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

  5. Autoimmune epilepsy - Diagnosis and treatment - Mayo Clinic

    These may include rituximab (Rituxan, Truxima, others), cyclophosphamide, mycophenolate (Cellcept, Myhibbin), azathioprine (Azasan, Imuran), or tocilizumab ( ...

  6. Idarubicin (intravenous route) - Side effects & uses - Mayo Clinic

    Cyclophosphamide; Ebola Zaire Vaccine, Live; Influenza Virus Vaccine, Live; Margetuximab; Paclitaxel; Paclitaxel Protein-Bound; Pertuzumab; Rotavirus Vaccine, ...

  7. Clinical trials - Oncology (Medical)

    The purpose of this study is to evaluate nab-paclitaxel as maintenance therapy after cisplatin-based chemotherapy and surgery in treating patients with ...

  8. Clinical trials - Oncology (Medical)

    Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to bring molecular risk prediction for breast cancer into the clinical arena through: the ...

  9. Clinical trials - Oncology (Medical)

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  10. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

    Requires systemic immunosuppressive treatment, including, but not limited to cyclophosphamide, azathioprine, methotrexate, thalidomide, and anti-tumor necrosis ...